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Summary
The present study was designed to define molecules and structures involved in the interaction
of natural killer (NK) cells with the vascular endothelium in vitro. Resting and interleukin 2
(IIs2)-activated NK cells were studied for their capacity to adhere to resting and 114-treated
human umbilical vein endothelial cells (EC) . In the absence of stimuli, NK cells showed appreciable
adhesion to EC, with levels of binding intermediate between polymorphs and monocytes . The
binding ability was increased by pretreatment of NK cells with 11,2. Using the appropriate
monoclonal antibody, the (32 leukocyte integrin CD18/CD11a was identified as the major
adhesion pathway of NK cells to unstimulated EC . Activation of EC with IIA increased the
binding ofNK cells. In addition to the CD18-CD11a/intercellular adhesion molecule pathway,
the interaction of resting or IL2-activated NK cells to IL-1-activated EC involved the VLA-4
(a413 1)-vascular cell adhesion molecule 1 receptor/counter-receptor pair. No evidence for ap-
preciable involvement ofendothelial-leukocyte adhesion molecule was obtained . Often, NK cells
interacted either with the culture substrate or with theEC surface via dot-shaped adhesion structures
(podosomes) protruding from the ventral surface and consisting of a core of F-actin surrounded
by a ring of vinculin and talin . The identification of molecules and microanatomical structures
involved in the interaction ofNK cells withECmay provide a better understanding ofthe regulation
of NK cell recruitment from blood, their extravasation, and their migration to tissues.
Lukocyte recruitment from the blood compartment is a
crucial determinant for the induction and expression of
immunity and inflammation . Leukocyte extravasation involves
adhesion to the endothelial lining of blood vessels and re-
sponse to tissue-derived chemotactic signals. Endothelial cells
(EC)1 play an active role in the control of leukocyte recruit-
ment by producing cytokines active on leukocytes and by ex-
pressing, in a regulated fashion, membrane proteins that are
substratum for adhesion of circulating cells (for review see
references 1-5) . Several ofthese molecules have been recently
identified and sequenced, including intercellular adhesion mol-
ecule 1 and 2 (ICAM-1 and -2) (6, 7), endothelial-leukocyte
adhesion molecule 1 (ELAM-1) (8), and vascular cell adhe-
sion molecule 1 (VCAM-1, also known as INCAM 110) (9,
10) . The expression of ICAM-1, ELAM-1, and VCAM-1 is
regulated bybacterial products (e.g., LPS) and cytokines (1-5) .
'Abbreviations used in thispaper: EC, endothelial cells ; ELAM, endothelial-
leukocyte adhesion molecule; ICAM, intercellular adhesion molecule ;
RPHD, rhodamine-labeled phalloidin ; VCAM, vascular cell adhesion
molecule .
Different leukocyte populations recognize "activated" EC
by means of different receptor/counter-receptor pairs . Poly-
morphs (PMN), but not lymphocytes, recognize ELAM-1
(8), whereas lymphocytes, via the integrin ct401 (VLA-4),
bind to VCAM-1 (10, 11) . VCAM-1 is also recognized by
monocytes, which may also bind to ELAM-1 (2) .
Cells with NK activity act as a first line ofresistance against
foreign cells, microbes, and possibly tumors (for review see
references 12 and 13) . Most bloodNK activity is mediated
by CD3 - , CD16+, CD56+ effectors . These cells, which
also mediate antibody-dependent cytotoxicity, have the TCR
genes in germline configuration and do not express a CD3/
TCR complex (12, 13) . The mechanisms involved in the regu-
lation of extravasation ofNK cells and their fate in tissues
are poorly understood . NK cells migrate promptly in vitro
(14-17) and adhere to and kill EC upon activation (18-21) .
The present study was designed to identify the molecular
structures involved in adhesion of resting and activated NK
cells to resting and activated EC . We show that unstimu-
lated NK cells have binding levels to resting EC intermediate
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Volume 173 February 1991 439-448betweenPMN and monocytes, and this involves the CD18/
CD11aadhesion pathway. Upon activation ofNK cells and/or
EC, augmented binding involves also the a4Ot/VCAM-1 in-
teraction pathway. A structural feature of NK cell interac-
tion withEC is theformationof"podosomes", which repre-
sent dot-shaped protrusions of the cellular ventral membrane
provided with adhesive properties and formed by a peculiar
cytoskeletal architecture . Podosomes have been identified in
a number of normal and transformed cells (22-25 ; reviewed
in 26), and are believed to be rapidly modulated adhesion
structures involved also in motility processes andin control-
ling the passage through anatomical barriers, including the
basement membrane (25, 27). Podosomes have been described
also in normal andmalignant blood cells (28, 29) and found
to be associated with the ,(3a/CD18 integrin complex .
Materials and Methods
Preparation of Leukocyte Populations.
￿
Normal human NK cells
were isolated on discontinuous Percoll gradients (Pharmacia Fine
Chemicals, Uppsala, Sweden) as previously described (14) . Low-
density cells were further depleted of monocytesby plastic adher-
ence and thereafter checked morphologically for the presence of
large granular lymphocytes (12, 13). In part of the experiments,
NK cells were depleted of monocytes and/or T lymphocytes by
treatment with saturating amountsofmAb anti-CD14 (kind gift
ofDr.J . Griffin, Dana Farber Cancer Institute, Boston,MA)and/or
anti-CD3 (Becton Dickinson&Co., Mountain View, CA) andDy-
nabeads (Unipath, Italy) ; aftertwo cycles ofDynabeads, the resulting
population contained <0.5-2% CD14*CD3* cells and >70-80%
CD16* and/or CD56* cells, by FRCS" analysis (Becton Dick-
inson & Co .) . Purified preparations of monocytes were separated
on Percoll gradients as reported (30) . PMN were isolated by Ficoll-
Hypaque gradient (BiochromKG, Berlin, FRG) andred cells were
lysed by hypotonic shock .
Activation ofNK Cells.
￿
NK cell preparations were resuspended
at 2 x 106/ml in RPMI 1640 (BiochromKG) plus 10% FCS(Hy-
clone Laboratories, Logan, UT), referred as complete medium, and
were activated by incubation with 100 U/ml 11,2 (Glaxo Imb.,
Geneva, Switzerland) for 24 h. At the end of the culture period,
cells were washedwith saline andresuspended in complete medium
for labeling . Control NK cells were incubated in medium alone .
Adhesion ofNK cells cultured in medium was not different from
that of freshly isolated cells.
Preparation ofEC .
￿
Human EC were obtained from umbilical
vein and cultured as previously described (31) . Routinely, we used
confluent cells (1Os/2-CMZ culture well) between the first and
fourth passage maintained in 199medium with 20% newborn calf
serum (Hyclone Laboratories) supplemented with endothelial cell
growth supplement (50,ug/ml; Collaborative Research, Inc., Lex-
ington, MA) and heparin (100 Ftg/ml; Sigma Chemical Co., St .
Louis, MO). The purity ofEC cultures waschecked by expression
of factor VIII antigen and found to be >99% positive .
Antibodies (Functional Assays).
￿
mAbs used in this study were
obtained through the courtesy ofthe following persons: two mAbs
directed against the common (3a subunit (CD18) of leukocyte inte-
grin, clone CLB54-LFA 1/1 (IgGl) (Dr . R. Van Lier CLB, Am-
sterdam, The Netherlands) and clone 1OF12 (Dr . J. Ritz, Dana
Farber Cancer Research Institute, Boston); mAb clone CLB-LFA
1/2 (IgG2a) directed against the aL subunit (CDlla) of LFAI (Dr .
440
R. van Lier) ; mAb clone 44a (IgG2a) directed against the am
subunit (CD11b) of Mac-1/CR3 (Dr . R. Todd, Ann Arbor, MI);
mAb clone L29 (IgGI), recognizing the ax subunit (CD11c) of
p150,95 (Dr . L. Lanier, Becton Dickinson & Co.); mAb anti-
ICAM-1, clone LB2 (IgG2b) (Dr . N. Hogg, ICR, London, UK)
and clone 6.5115 (IgGl) (Dr . D. Haskard, Guy's Hosp., London,
UK); mAbantiVLA4, cloneHP2/1(IgGl)(Dr . F . Sanchez-Madrid,
University of Madrid, Madrid, Spain) ; mAb antiVCAM-1, clone
4139 (IgGl) (Dr . J . Harlan, University ofWashington, Seattle,WA);
and clone E1/6 (IgGI) (Dr.M. Bevilacqua, Harvard Medical School,
Boston, MA); and mAb anti-ELAM-1, clone H4/18 (IgGl) (Dr.
M. Bevilacqua) . These reagents havepreviouslybeen shown torecog-
nize functionally relevant epitopes (32-40).
Results shown in Fig . 4-7 refer to mAb CLB54-LFAl/l for
CD18 ; LFA1/2 for CD11a ; 44a for CD11b; L29 for CD11c; LB2
for ICAM-1 ; 4119 forVCAM-1 ; HP2/1 for VLA-4; andH4/18 for
ELAM-1, but similar data were obtained with the alternative ap-
propriate reagents directed against the same structure.
mAbs were used as ascites after dialysis at a previously deter-
mined optimal concentration of 1/300, or as hybridoma superna-
tant diluted 1/5 to 1/10 . mAbs recognizing leukocyte structures
were incubatedduring the adhesion assay; mAbs recognizing struc-
tures on EC were pre-incubated with the EC monolayer for 20
min at 37°C and left in the medium during the adhesion assay.
In each experiment, isotype-matched antibodies were used as nega-
tive control : mAbIgGI (clone 21, Thy-21)3, anti-CD8), mAbIgG2a
(clone 19, Thy-5D, anti-CD4), and mAb IgG2b (clone 24T6G12,
anti-CD5) .
Antibodies (Immunofluorescence Assays).
￿
The localizations ofvin-
culin and talin were, respectively, assayed with a mAb to vinculin
(41) from Bio Makor, Rehovot, Israel (VIN 11-5 ; no. 6501) and
a mAb crosrreacting with human talin, clone 8D4 (42), obtained
from Dr.K. Burridge, University of North Carolina, Chapel Hill,
NC . mAbs antiVLA4 B-5G10, toas (11) and anti-/3,, andAIA5
(43) were a kind gift of Dr.M. Hemler, Dana Farber Cancer In-
stitute.
Adhesion Assay.
￿
Adhesion of leukocytes to EC was studied as
described previously (30) . EC were grown to confluence in flat-
bottomed 96-well trays and, in some experiments, were activated
for 20 h with 10 ng/ml of IIr10 (sp act, 8 x 106 U/p,g) (Sclavo,
Siena Italy) unless otherwise specified .
Leukocytes were resuspended in complete medium at 10'/ml
and labeled with 100 P.Ci "Cr (sodium chromate ; Amersham In-
ternational, Amersham, UK) at 37°C for 1 h. At the end of the
incubation, the cells were washed with medium and were
resuspended at 106/ml; then, 0.1 ml was dispensed to each well
andincubated for 30 min at 37°C . At the end of the incubation,
the wells were carefully washed three times with PBS + 1% FCS;
adherent cells were solubilized with 0.2 ml of0.025MNaOH and
0.1% SDS, and radioactivity was counted in a gamma counter.
Results are presented as percentage of adherent cells ± SD, with
three to five replicates/group. Levels of statistical significance were
calculated by Student's t test. In one series of experiments, HT29
coloncarcinoma cells were used as reference population, in as much
as the augmented binding of thesecells to IIr1-activatedEC is medi-
ated via ELAM-1 (see Results) .
Preparation of NK Cells for Analysis of Adhesion Structures.
Adhesion of11,2-activatedNK cells was studied both on uncoated
glass coverslips as well as on coverslips coated by a pre-formed EC
monolayer. Cells were processed as previously described (28). Briefly,
coverslip-attached cells were fixed in PBS containing 3% parafor-
maldehyde and 2% sucrose (pH 7.6) for 5 min at room tempera-
ture andpermeabilized in Hepes-Triton buffer (20mM Hepes, pH
Interaction of Natural Killer Cells with the Vascular Endothelium7.4, 300 mM sucrose, 50mM NaCl, 3 MM MgC12, and 0.5%
Triton X100) for 5 min at 0°C, and finally rinsed in PBS . To show
F-actin, fixed and permeabilized cells were stained with 2 hg/ml
rhodamine-labeled phalloidin (R-PHD ; Sigma Chemical Co.) for
30 min at 37°C . Indirect immunofluorescence experiments were
performed as reported (28). Briefly, the primary antibody was layered
on fixed and permeabilized cells and incubated in a humid chamber
for 30 min . After rinsing in 0.1% BSA in TBS, coverslips were
incubated in the appropriate rhodamine-tagged secondary antibody
(Dakopatts, Glostrup, Denmark) for 30 min at 37°C in the pres-
ence of 2 Ag/ml of fluorescein-labeled phalloidin (F-PHD ; Sigma
Chemical Co.), rinsed, and mounted in Mowiol 4-88 (Hoechst,
Frankfurt/Main, FRG) .
Observations were carried out in an Axiophot photomicroscope
(Carl Zeiss, Inc ., Thornwood, NY) equipped for epifluorescence
and interference reflection microscopy. Fluorescence images were
recorded on Kodak TMax 400 films exposed at 1,000 ISO and de-
veloped in Kodak TMax developer for 10 min at 20°C .
Results
Adhesion ofResting andActivatedNK Cells to EC
￿
Leuko-
cytes are heterogeneous in their ability to adhere to EC in
the absence of stimuli, with PMN exhibiting minimal and
monocytes high "spontaneous" binding. As shown in Fig.
1 A, NK cells had intermediate levels of spontaneous adhe-
sion to EC with 16 ± 8% binding (mean ± SD ; range
5-25%, of five experiments), compared with 40 ± 13 of
monocytes (five experiments) and 7 ± 3% of PMN (seven
experiments), as measured after 30min . Similar results were
obtained at all time points examined (Fig . 1 B) .
We have studied the influence of stimuli on the interac-
tion ofNK cells with EC . IL-2 and 111 were used as proto-
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Figure 1 .
￿
Leukocyte adhesion to monolayers of human EC. Percent adhe-
sion ofs1Cr-labeled polymorphs, monoayees, andNK cells was determined
after 30-min incubation (A) or at earlier time points (B) . Values represent
mean ± SD of five to seven different experiments .
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typic activation signals for NK cells and EC, respectively (5,
13) . As shown in Fig. 2, NK cells exposed to IL-2 (100 U
for 24 h) showed a 2.5-fold increase in binding to EC, with
41 ± 13% adhesion . Similarly, when EC were exposed to
1171 (10 ng/ml for 20 h), stimulated binding of resting NK
cells (37 ± 12% in five experiments) was observed . The max-
imal level of binding (49 ± 7%) was observed when both
NK cells andEC were stimulated with the appropriate respec-
tive stimulus. The experimental conditions used for these ex-
periments were chosen after preliminary experiments had
shown that they were optimal for NK cell adhesion to EC .
Optimal activation ofNK cells for binding was observed with
IL-2 concentrations ranging from 100 to 1,000 U/ml, consis-
tent with previous results and with the constitutive expres-
sion of the intermediate affinity IL2 receptor by these cells
(13) . Maximal increase of the capturing capacity ofNK cells
was observed at IL1 concentrations >0.5 ng/ml, as for other
functions of EC (e.g., 5,30,31) .
Distinct adhesion molecules induced in EC by ILl are ex-
pressed with distinct time courses (1-5) . Cytokine-induced
ELAM-1 expression is maximal at 4-6 h and declines there-
after, whereas expression of ICAM-1 and VCAM-1 is sus-
tained for 24 h or longer (8-10) . The distinct temporal ap-
pearance ofthese three adhesion molecules in IL-1-stimulated
EC was confirmed in experiments preliminary to the present
study (not shown) . For the above reasons, in a series of ex-
periments, we examined the time course of increased binding
ofNK cells to IL-1-treated EC. As shown in Fig. 3, where
results of three experiments are presented, sustained binding
to 11,1-treated EC was already detected at 4 h, with no in-
crease or decrease up to 24 h .
Adhesion molecules involved in Binding to RestingEC.
￿
The
role of different adhesion structures in binding ofNK cells
toEC was then examined . Representative results are presented
in Fig. 4-7. The interaction of unstimulated NK cells with
resting EC was first examined . Fig. 4, A and B shows one
typical experiment . Anti-CD18 mAb caused 80 ± 12% in-
hibition ofbinding (mean ± SD of five experiments) . When
the role of the three different (32 integrins (aL02 or LFA-1;
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￿
Adhesion of resting or 11,2-activated NK cells (100 U/ml of
11,2 for 24 h) to resting EC or pretreated for 24 h with 10 ng/ml of ILl .
Percent adhesion was determined after 30-min incubation at 37°C of 51Cr-
labeled cells . Values represent mean ± SD offour different experiments .Z
O_
to w
0
d
0
IL-1 TREATMENT (h)
Figure 3.
￿
Kinetic analysis of IIL1 activation of EC. Percent NK cell
adhesion was determined with 51Cr-labeled cells. a, b, and c represent in-
dependent experiments . SD were always <3-5% and were omitted for
clarity.
aM02 or Mac 1 ; aX02 or p150,95) was studied, only anti-
CD11a/LFA-1 antibodies inhibited binding (67 ± 10%) . It
must be emphasized that the anti-CD11b and anti-CD11c
mAbs used in this study recognize functionally relevant epi-
topes (34-36) . Anti-ICAM-1, anti-ELAM-1, antiVLA-4, and
antiVCAM-1 had no consistent and significant effect .
Anti-CD18 and anti-CD11a mAbs caused a 57 ± 24%
and 32 ± 7% inhibition, respectively, ofthe increased binding
of IL-2-activated NK cells to resting EC (mean of four ex-
periments, one shown in Fig. 4 D) . Anti-ELAM-1 and anti-
VLA4 (C) had no inhibitory activity, while anti-ICAM-1
caused 36 ± 7% inhibition (range 30-46%) in four experi-
ments, and its effect was not significant in one .
Adhesion Molecules Involved in Binding to ActivatedEC.
￿
The
interaction of resting NK cells with IL-1-stimulated EC was
mAb added
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then analyzed (Fig . 5, A and B) . As for the binding to resting
EC, anti-CD18 and anti-CD11a mAbs caused substantial in-
hibition of adhesion (45.6 ± 11% and 44 ± 5%, blocking
in four experiments, one of which is shown in Fig. 5 B) .
Interestingly, the interaction of I1,2-activated NK cells with
IIs1-treated EC was inhibited by these mAbs to a lesser de-
gree (31 ± 6% and 24 ± 2% inhibition, respectively, four
experiments), as compared with any other cell combination
(Fig. 5 D) .
Anti-ICAM-1 mAb caused appreciable inhibition ofbinding
of both resting and activated NK cells with 36 ± 3% and
22 ± 10% inhibition, respectively (Fig. 5,A and C) . Anti-
ELAM-1 mAb had no substantial effect on binding to acti-
vatedEC (Fig. 5, A and C) . These results were obtained with
anti-ELAM-1 mAb, clone H4/183, and cloneBBIGE8 (results
not shown, courtesy ofDr. J . Gordon, BBL, Oxford, UK) .
The results presented in Figs . 4 and 5 refer to EC pretreated
with 11,1 for 20 h . It was important to evaluate the involve-
ment ofELAM-1 after 4-6 h of exposure to ILL when ex-
pression of this structure is maximal (8) . As illustrated by
the experiment presented in Fig . 6 A, at no time point did
anti-ELAM-1 mAb influence binding ofNK cells to activated
EC . It is noteworthy that under these conditions, anti-ELAM-1
inhibited the augmented binding of colon carcinoma cells
HT29 (80% blocking) to IL1-treated EC (Fig. 6 B) .
AntiVLA-4 and antiVCAM-1 mAbs appreciably reduced
binding (36% and 25% inhibition) ofunstimulatedNK cells
to activated EC (Fig . 5 A) . These mAbs did not substan-
tially affect the adhesion of activated NK cells ; a representa-
tive experiment is shown in Fig. 5 C .
In an effort to obtain better identification of the role of
the VLA-4 adhesion pathway, combinations of anti-CD18
and antiVLA-4 mAbs were studied (Fig. 7) . After inhibi-
tion of the CD18 adhesion pathway, the blocking effect of
Figure 4 .
￿
Inhibition ofNK cell adhe-
sion to restingEC by individual mAb.
51Cr-labeled resting NK cells (A and
B) and IL2-activatedNK cells (C and
D) were incubated for 30 min on EC
monolayers in the presence ofoptimally
diluted mAb. AntiVCAM-1, anti-
ELAM-1, and anti-ICAM-1 mAbs were
pre-incubated for 20 min on EC alone .
Values represent mean ± SD of three
to five replicates . (*) Statistically sig-
nificant at p < 0.05 vs. negative con-
trol . (**) Sttitilly significant at asc
mAb added
￿
p < 0.01 vs. negative control .
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antiVLA-4 mAb on binding of resting (Fig . 7 A) and acti-
vated (B) NK cells to IL-1-treated EC was clearly and con-
sistently detectable. Combinations of anti-ICAM-1 with
anti-CD18 mAb were not different from those obtained with
anti-CD18 alone.
To identify a possible role of ELAM-1, a mAb directed
against this molecule was added to combinations of anti-
VLA-4 and CD18 . Alto under these conditions, anti-ELAM-1
mAb was devoid of appreciable activity (Fig . 7 B) .
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Figure 6 .
￿
Inhibition ofNK cell and colon carcinoma (HT29) cell adhe-
sion on activated human EC by anti-ELAM-1 mAb. Adhesion assay was
performed at different time points after IL-1 activation of EC . Open bars
and hatched barsrefer to control and anti-ELAM-1-treated cultures, respec-
tively.
ACTIVATEDNK CELLS
Figure 5.
￿
Inhibition ofNK cell adhe-
sion to 11,1-activated EC by individual
mAb. RestingNK cells (A and B) and
11,2 activatedNK cells (C and D) were
incubated for30 minonEC monolayers
in the presence of optimally diluted
mAb. Values represent mean ± SD of
three to five replicates. (*) Statistically
significant atp < 0.05 vs . negative con-
trol . (* *) Statistically significant at,p
mAbadded
￿
< 0.01 vs. negative control .
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These results indicate that CD18/CD11a and VLA-4 are
important pathways ofadhesion ofNK cells to endothelium .
Expression of ,(32 integrins on NK cells has been extensively
characterized (13, 37) . It was important to analyze the ex-
pression of VLA-4 on resting and IL-2-activated NK cells.
As shown in Fig . 8, where one representative experiment of
three performed is shown, NK cells expressed VLA-4, an ob-
servation that confirms a recent report (44) . Expression of
VLA-4 was not appreciably altered after 11,2 activation, as
judged by fluorescence intensity.
Adhesion Structures Involved in theNKEC Interaction .
￿
The
adhesion of IL2-activated NK cells was studied by fluores-
cence microscopy upon seeding cells on unstimulated and IL
1-stimulated EC monolayers . The stimulation of EC with
IL1 increased the number of adherent NK cells by at least
threefold . These data were obtained by observing cells stained
with R-PHD, which binds to F-actin . Many NK cells dis-
played irregular shape and membrane ruffles, indicating that
they were undergoing active locomotion on theEC monolayer
(Fig. 9, a and b) . EC-adherent NK cells showed strong mem-
brane positivity for the CD11a/LFA-1 integrin complex, as
shown by CD18/02 mAb (Fig. 9 c) and an ci,/CD11a mAb
(Fig . 9 d) . AlsoVLA-4 was expressed on NK cell membrane,
although at a somewhat weaker extent (Fig. 7 e) . In any case,
these integrin heterodimers were not expressed by the un-
derlying EC, as expected, but a control with a 01 mAb
(A-1A5) showed that other 01 integrins were expressed by
EC (data not shown ; e.g. reference 45) .
10-20% of the NK cells that had firmly adhered to the
EC monolayers displayed a peculiar distribution of F-actin
in 0.2-0.4-Ncm punctate dots (Fig. 9, a and b, e.g., at arrow-
heads), which were identical to the dot-like close contact adhe-
sion sites that we had previously described in many normal
and transformed cell types (22-25) and denoted as podosomes.
Podosomes were also displayed byNK cells seeded on glassNEG
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(not shown) . Under these conditions, the podosomes ofNK
cells were better observed in the absence of any interfering
signal from underlying EC . We could confirm thatNK cell
podosomes displayed the typical ring-like distribution of vin-
culin, talin, and CD18 already described in other cell types
(22-25) . We could not obtain a good high resolution pat-
tern of vinculin and talin on NK cells seeded on EC because
the latter are very rich in vinculin and talin and gave a strong
background signal (45) .
Discussion
The present study identifies receptor/counter-receptor sys-
tems and structures involved in the interaction ofNK cells
with EC . Unstimulated NK cells adhered significantly to
resting EC, with binding capacity intermediate between that
ofPMN and monocytes. It was already reported that among
nonphagocytic lymphoid cells, NK cells show increased ability
to adhere to EC (18-20) .
In this study, the 162 leukocyte integrin CD18/CD11a
(LFA 1) was identified as the main adhesion structure involved
in the NK/EC interaction in the absence of stimuli . Inhibi-
tion oflymphocyte binding by anti-CD11amAb has already
been reported for T cells (46, 47), and in one report for cells
with NK characteristics (18) . Members of the leukocyte (32
integrin family areknown to play an important role in adhe-
sion of PMN and monocytes to EC . Binding of monocytes
NK
cells
IL-2
activated
NK
cells
Neg CD18 VLA-4
Figure 8.
￿
Flow cytometric analysis of resting and 11,2-activated (24 h)
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Figure7 .
￿
Inhibition ofNK cell adhe-
sion to 111,1-activated EC by combina-
tions of mAbs. Resting NK cells (A)
and IIr2-activated NK cells (B) were in-
cubated onEC monolayers in the pres-
ence ofoptimally diluted mAbs. Values
represent mean ± SD of three to five
replicates . (*) Statistically significant at
p < 0.05 vs . negative control . (**)
Statistically significant at p < 0.01 vs .
negative control.
and PMN to EC involves, in addition to CD11a, also CD11b
and, to a very minor degree, CD11c (p150, 95) (30, 34) . NK
cells express CD11b (Mac 1) and CD11c/p150,95 (13, 37),
but we failed to identify a functional role for these structures
in binding of these cells to EC . This apparent discrepancy
in Mac-1 involvement between phagocytes andNK cellsmay
reflect a difference in the amount of this molecule expressed
on the surface as well as a difficulty in identifying a role for
minor adhesive components in the presence of relatively low
levels of binding .
The 02 integrin CD18/CD11a recognizes ICAM-1 and
ICAM-2 (6, 7) . ICAM-2 is constitutively expressed by EC,
whereas ICAM-1 is present at relatively low levels and is in-
creased by cytokines (1, 7) . Since anti-ICAM-1 mAb had no
effect on binding of resting NK cells to unstimulated EC,
we infer that the main receptor/counter-receptor system in-
volved in this interaction is LFA1/ICAM-2 .
ActivatedNK cells have increased ability to adhere to resting
EC . These cells have been shown to kill EC (19, 21), a
phenomenon thatmay be important in the vascular leak syn-
drome associated with lymphokine-activated killer/11,2 therapy
(48) . As for resting NK cells, the CD18-dependent pathway
accounted for 60% ofbinding of activated NK cells to un-
stimulated EC .
A major objective ofthe present study was to identify adhe-
sion pathways involved in the interaction of NK cells with
Ilrl-activated EC, which have increased capacity to capture
leukocytes . As for binding to restingEC, anti-CD18/CD11a
inhibited adhesion . Binding ofNK cells to activatedEC was
also consistently reduced by anti-ICAM-1, an observation that
reflects the increased expression of this molecule in EC ex-
posed to IIr1(1, 2) . It is ofinterest to highlight the fact that
/32 integrin antibodies caused less inhibition of binding to
I1r1 treated than to resting EC (45 ± 12% vs. 80 ± 11% ;
p < 0.01) . The level of such inhibition was inversely propor-
tional to the extent of EC activation and this finding sug-
gests the involvement of other IIr1-induced adhesion mech-
anisms .
VCAM-1 is a recently identified adhesion molecule induced
on endothelium by rytokines and LPS (9, 10) . The leuko-
cyte receptor for VCAM-1 is a401/VLA4 (CD49d) (11) .
VCAM-1 is an adhesion molecule recognized by normal and
leukemic T andB lymphocytes as well as by monocytes and
myeloid leukemic lines (9, 10) . AntiVLA4 and antiVCAM-1Figure 9 .
￿
Fluorescence detection ofNK cells on EC monolayers by means of F-actin staining with R-PHD. The focus was adjusted on NK cells
and, therefore, the underlying EC are only barely visible . Some of the NK cells display dots of F-actin (e.g., at arrowheads) both on unstimulated
(a) and IIA stimulated (b) EC monolayers. c, d, and e, respectively, show the immunofluorescence localization of CD18/02, CD11a/uL, and VLA4/tx4
on NK cells that had adhered on IL-1-stimulated EC cell monolayers. Bar denotes 15 um .
mAbs had some, but modest, effect on NK binding to acti-
vatedECwhen used alone. In contrast, when the CD18 adhe-
sion pathway was blocked by an appropriate mAb, a role for
the VCAM-1/VLA4 receptor/counter-receptor interaction
was clearly identified and accounted for -34% of binding
of activated NK cells to IL-1-treated EC (Fig. 7) . Blocking
of CD18 was also required to highlight the role of VLA-4
in a recent study on binding of monorytes to EC (2, 49) .
ELAM-1 binds neutrophils and some leukemic myeloid cells,
but not lymphocytes and lymphocytec lines (8) . The capacity
ofELAM-1 to bind monorytes is not clearly defined (39, 50),
but recently, it was found that mononuclear phagocytes recog-
nize ELAM-1 expressed inCHO cells (Carlos, T.M . et al.,
manuscript submitted for publication) . In the present study,
anti-ELAM-1 did not affect the interaction of NK cells
with EC. Moreover, we did not find a role for this protein
combining anti-ELAM-1 mAb with anti-CD18 (± anti-
VLA4), a condition that demonstrated the role played by
VLA-4/VCAM-1 . Two anti-ELAM-1 mAbs were used, under
conditions in which they blocked the augmented binding of
colon carcinoma cells (HT29) to I11,1-activated EC (Fig. 6)
and PMN (not shown) . Thus, these observations suggest that
445
￿
Allavena et al .
ELAM-1 is not an important structure for the adhesion of
NK cells to vascular EC.
In the presence of saturating concentrations of anti-CD18
and antiVLA-4mAbs (± anti-ELAM-1), adhesion of a sub-
stantial proportion ofresting and activated NK cells (25-30% ;
Fig. 7) on activated EC was clearly detectable. Conceivably,
the interesting possibility exists that unknown adhesion path-
ways, other than those identified in the present study(CD18/
CD11a-ICAM andVLA-4VCAM-1), may play a role in the
interaction of NK cells with vascular EC .
The results presented here identify adhesion molecules and
structures involved in the interaction of NK cells with vas-
cularEC . Relatively little information is available on the regu-
lation of NK cell extravasation and localization in tissues.
NK cells can be identified morphologically and functionally
in the peritoneal cavity ofmice early after the intraperitoneal
inoculation of bacterial agents (51) . Cells with NK activity
and phenotype accumulate during virus infection in the liver
and at sites of virus replication (52-57) . Early after trans-
plantation, NK cells can be identified in allografted tissues
(55) . After administration of biological response modifiers,
NK cells localize in certain tissues, particularly in the liver(56) . On the other hand, NK cells generally represent a minor
proportion oflymphoid cells infiltrating tumor tissues (13, 57) .
The adhesion ofNK cells to EC or to other culture sub-
strates involves the appearance of peculiar dot-like adhesion
structures called podosomes (22-25), whichhave already been
described in other lymphoid cells (28) and in normal andmalig-
nant monocytes (29) . Podosomes are not displayed by all ad-
herent NK cells but only by a variable proportion of them .
Such irregular distribution mayjust reflect the fact that podo-
somes are also involved in extracellular proteolysis (27) and
may appear only in those cells that are actively engaged in
attacking extracellular structuresand particularly in making
their way across basement membranes (25) .
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